REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 26 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,229,880 | -23.3% | 4,000,000 | 0.0% | 0.02% | -19.0% |
| Q2 2023 | $4,213,720 | -14.7% | 4,000,000 | 0.0% | 0.02% | -12.5% |
| Q1 2023 | $4,941,000 | +33.0% | 4,000,000 | 0.0% | 0.02% | +41.2% |
| Q4 2022 | $3,714,640 | -14.0% | 4,000,000 | 0.0% | 0.02% | -15.0% |
| Q3 2022 | $4,317,000 | +29.2% | 4,000,000 | 0.0% | 0.02% | +42.9% |
| Q2 2022 | $3,342,000 | -11.2% | 4,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $3,765,000 | +5.2% | 4,000,000 | 0.0% | 0.01% | +7.7% |
| Q4 2021 | $3,578,000 | -22.0% | 4,000,000 | 0.0% | 0.01% | -35.0% |
| Q3 2021 | $4,585,000 | -2.0% | 4,000,000 | 0.0% | 0.02% | -4.8% |
| Q2 2021 | $4,680,000 | +3.4% | 4,000,000 | 0.0% | 0.02% | -16.0% |
| Q1 2021 | $4,526,000 | – | 4,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| READYSTATE ASSET MANAGEMENT LP | 17,500,000 | $21,551,250 | 2.00% |
| CSS LLC/IL | 17,325,000 | $21,353,288 | 1.41% |
| SSI INVESTMENT MANAGEMENT LLC | 7,938,000 | $9,735,966 | 0.68% |
| Boussard & Gavaudan Investment Management LLP | 5,000 | $6,146,212 | 0.58% |
| Context Capital Management, LLC | 3,249 | $4,001 | 0.34% |
| LINDEN ADVISORS LP | 20,000,000 | $24,645,586 | 0.26% |
| AVIVA PLC | 22,325,000 | $27,381,613 | 0.12% |
| DeepCurrents Investment Group LLC | 2,384,000 | $2,931,980 | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 35,500,000 | $43,718 | 0.06% |
| D. E. Shaw & Co., Inc. | 34,364,000 | $42,380,365 | 0.04% |